T h e ne w e ngl a nd jou r na l o f m e dic i ne n engl j med 363;2 nejm
clear cornea is essential to visual acuity and depends on stromal avascularity and epithelial integrity. 1 Corneal renewal and repair are mediated by stem cells of the limbus, the narrow zone between the cornea and the bulbar conjunctiva. 2 Ocular burns may destroy the limbus, causing limbal stem-cell deficiency. In such cases, the cornea acquires an epithelium through the invasion of bulbar conjunctival cells. This process leads to neovascularization, chronic inflammation, and stromal scarring, with corneal opacity and loss of vision. 3 Allogeneic corneal transplantation (keratoplasty) restores transparency temporarily, but eventually, the conjunctival cells begin to invade and resurface the cornea. The only way to prevent this invasion is to restore the limbus. Such restoration has been attained in cases of unilateral limbal stem-cell deficiency through the grafting of limbal fragments obtained from the uninjured eye. 4 Under appropriate culture conditions, human keratinocytes generate holoclones, meroclones, and paraclones, all of which are capable of proliferation. 5 Holoclone-forming cells are the stem cells of virtually all human squamous epithelia 2, 6, 7 and are required to permanently restore massive epithelial defects. [6] [7] [8] In humans, holoclone-forming cells are located in the limbus but not in the central cornea. 9, 10 Paraclones, which are derived from holoclones, have the properties of transient amplifying progenitor cells. 5, 9 Meroclones have intermediate proliferative and clonogenic potential; they give rise to and are a reservoir for paraclones. 5, 9 Human limbal stem cells can be identified, both in vivo and in vitro, through their expression of the p63 transcription factor. 11-13 The TP63 gene generates six isoforms. 14 Transcription from different promoters generates two different premessenger RNAs: TAp63 and ΔNp63. Alternative splicing of each transcript produces α, β, and γ isoforms. 14 Ocular keratinocytes may contain all the ΔN isoforms, but ΔNp63α (hereafter referred to as p63) is by far the most abundant 11, 12 ; it is present in the limbus but not in the uninjured central cornea 12, 13 and is expressed in holoclones but not in paraclones. 12 The protein p63 sustains the proliferative potential of limbal stem cells, and the C/EBPδ transcription factor maintains the self-renewal of these cells and regulates their mitotic rate. 13 During corneal repair, limbal stem cells that stain intensely (hereafter referred to as p63-bright cells) are released from C/EBPδ-dependent mitotic constraints, multiply, and migrate to regenerate corneal epithelium. 13 The finding that human limbal cell cultures 15 contain holoclones 9 led to the first therapeutic use of such cultures in the regeneration of corneal epithelium. 16 Autologous limbal cell cultures also offer an opportunity to treat patients who have severe bilateral loss of corneal epithelium, provided that a tiny part of the limbus is spared in one of the two eyes; thus, it is not applicable in cases of total bilateral limbal stem-cell deficiency. Related studies have been reported, 6,17 but they have been limited because of the comparatively small numbers of cases, the relatively short follow-up, and the heterogeneity among causes of the disorders and among the sources of transplants and cell cultures. We report the long-term results of a study in which we used this approach to treat patients with corneal damage from common causes.
Me thods

Patients
Patients with severe or total, unilateral or partial burn-related lateral limbal stem-cell deficiency were included in the study. (For details, see Table 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org.)
Cell Culture and Treatment
Autologous limbal stem cells were obtained from a biopsy specimen (1 to 2 mm 2 ) taken from the patient's contralateral eye, and the cells were cultured on fibrin, a natural substrate that preserves holoclone-forming cells. [18] [19] [20] Clinical-grade-certified, lethally irradiated 3T3-J2 cells from a master cell bank were used as feeder cells. Details of cell culture, graft preparations, immunohistochemical tests, and surgical and postoperative procedures are described in the Supplementary Appendix.
Follow-up and Assessment of Outcome
Follow-up evaluations were performed according to standard procedures; for details, see the Supplementary Appendix. The outcome of treatment was assessed at 1 year. The treatment was considered to be successful if all symptoms had disappeared and a transparent, avascular, and stable corneal surface had been restored and was con-sidered to be partially successful if most symptoms had disappeared but superficial neovascularization had recurred, even if it was not as extensive as at the time of admission. Treatment failure was defined as the presence of symptoms, recurrent epithelial defects, pannus, and inflammation at 1 year. Three observers assessed the clinical results; two were involved in the patients' care, and the third did not participate in any biologic or clinical procedure.
Statistical Analysis
We analyzed results with the use of the KaplanMeier, chi-square, Mann-Whitney, McNemar, and Kruskal-Wallis tests as well as univariate and multivariate stepwise logistic-regression analyses (as described in the Supplementary Appendix).
R esult s
Characteristics of the Patients
We studied 113 eyes from 112 patients enrolled between 1998 and 2006. The mean (±SD) age of the patients was 46.5±14.4 years (range, 14 to 80), and 78.6% of them were men. The limbal stemcell deficiency ranged from severe (in 35.4% of the patients) to total (in 64.6%) (Table 1 in the Supplementary Appendix). The most common causes of limbal stem-cell deficiency (in 97.3% of cases) were chemical burns (83 alkali, 16 acid, and 4 other) and thermal burns (7) . Two patients had a bacterial infection and one patient had undergone orbit irradiation. Patients had unilateral (87.5%) or bilateral (12.5%) burns; only two patients had bilateral severe limbal stem-cell deficiency (Patients 24 and 83 in Table 1 in the Supplementary Appendix). Most of the eyes (84%) had been treated previously with surgery (in some cases multiple surgeries), but all surgical treatments had failed, probably because of an insufficient number of residual limbal stem cells to regenerate corneal epithelium. Twenty-eight patients had undergone a single unsuccessful keratoplasty, and 20 had undergone multiple unsuccessful keratoplasties. Before this study, optimally corrected visual acuity was less than 0.1 (i.e., light perception, hand movement, and counting fingers) in 88.5% of the patients and was 0.1 to 0.5 in 11.5% of the patients. The baseline features of the patients, including diagnoses and grading of limbal stem-cell deficiency, are provided in the Supplementary Appendix. The clinical outcome of limbal stem-cell transplantation was judged to be successful in 76.6% of the eyes (Table 1) .
The mean time between injury and the first graft was 18.3±16.7 years (median, 12.9; range, 0.8 to 56.4). No intraoperative complications were reported. Postoperative adverse events included hemorrhage (in 12 patients), residual fibrin on the third postoperative day (in 11 patients), inflammation (in 59 patients), blepharitis with epithelial involvement (in 35 patients), and herpetic keratitis (in 3 patients) ( Table 1 in the Supplementary Appendix), all of which were treated with the use of standard therapy.
Regeneration of Corneal Epithelium
The human corneal epithelium is renewed approximately every 9 to 12 months. 1 Since we therefore surmised that the regenerated epithelium would persist for 1 year after transplantation only if the stem cells had successfully engrafted, 8 we carried out the first conclusive clinical evaluation after at least 1 year of follow-up. Six patients did not complete the study and were excluded from the analysis. We report the results obtained during a maximum of 10 years of follow-up for the remaining 106 patients, with a mean follow-up period of 2.91±1.99 years and a median of 1.93 years (interquartile range, 1.02 to 3.67). One year after surgery, the 107 transplants were scored as success, partial success, or failure in 73 eyes (68.2%), 18 eyes (16.8%), and 16 eyes (15%), respectively (Table 1) . Of 11 eyes (representing 12 grafts, since 1 eye was regrafted twice), 6 were partially successful and 5 were considered to have failed; these 11 were all regrafted with cultures prepared from frozen cells taken from the original biopsy specimen or from cells cultured from a new biopsy specimen. In 9 of these eyes, normal epithelium was regenerated after regrafting.
Thus, the final clinical outcome was classified as a success in 82 eyes (76.6%), a partial success in 14 eyes (13.1%), and a failure in 11 eyes (10.3%) ( Table 1 ). Grafts that were considered successful at 1 year after surgery invariably remained stable thereafter, with a transparent avascular cornea covered by normal corneal epithelium (Fig. 1) . Grafts that were considered failures at 1 year did not worsen in subsequent years as compared with baseline.
Univariate logistic-regression analysis showed that failures were associated with a number of factors, including age, the cause of limbal stemcell deficiency, previous surgical procedures, the severity of damage, culturing and graft-transport complications, postoperative complications, and inflammation (Table 2) . On multivariate logisticregression analysis, failures were still significantly associated with the severity of damage and with culturing, graft-transport, and postoperative complications (Table 2) . Post hoc analyses showed no significant difference in the likelihood of success between eyes that were also treated with keratoplasty (71%) and eyes that were not (79%).
Criteria for Graftable Limbal Cultures
The average percentage of clonogenic cells detected in cultures was similar for successful, partially successful, and failed transplants (37.2%, 31.1%, and 35.5%, respectively). But the percentage of colony-forming cells is inadequate as an indication of the percentage of stem cells, because it is not possible to visually identify holoclones. 5, 9 Determining the number of holoclones by means of clonal analysis is both cumbersome as a routine procedure 5,9 and unsuitable for preoperative quality control because the results become available only after grafting. In contrast, quantitative immunodetection of p63, a marker of holoclones, is straightforward and can be performed before grafting. 6, 21 We were able to examine the relationship be- Panel A shows the survival estimates for the cultures after one graft was placed, with partial or total success attained in 68.2% of the eyes treated. Panel B shows survival estimates after a second graft was placed in 11 eyes (a total of 12 additional grafts, since 1 eye was regrafted twice), indicating either partial success or failure. After regrafting, 9 of these eyes regenerated normal epithelium. Thus, the final clinical outcome was deemed a success in 76.6% of the eyes treated. All failures occurred within the first year after grafting, whereas successful cultures remained stable for up to 10 years of follow-up.
The were unable to analyze this relationship in all patients because p63 was not found to be a marker of limbal stem cells until 2001. 11 ) A post hoc Kruskal-Wallis analysis showed that cultures giving rise to successful grafts contained a significantly greater percentage of p63-bright cells than those giving rise to unsuccessful grafts (P<0.001) ( Fig. 2A ). Grafts associated with partial success were obtained from cultures with an intermediate percentage of p63-bright cells. In additional post hoc analyses, we evaluated the clinical results according to culture status. Cultures that contained more than 3% p63-bright cells led to successful corneal epithelial regeneration in 78% of the eyes (Fig. 2B) , and only 8% and 14% of such cultures were associated with failed or partial regeneration, respectively. In contrast, cultures in which 3% or less of the cells were p63-bright were successful in only 11% of eyes and were unsuccessful or partially successful in 67% and 22% of eyes, respectively. Thus, the percentage of p63-bright cells in the culture was positively associated with the clinical outcome of limbal stem-cell grafting. These data are consistent with the finding that the human limbus contains at least 5% stem cells. 9 On the basis of these data, we now use only cultures that contain more than 3% p63-bright cells to prepare grafts.
That said, a defined percentage of stem cells is necessary but not sufficient to ensure a good clinical result. Approximately 20% of cultures that contain more than 3% p63-bright cells were associated with failed or only partially successful treatment (Fig. 2) , suggesting that other factors, such as the severity of injury and the presence or absence of complications, also influence outcome.
Restoration of Visual Acuity
The regeneration of normal avascular corneal epithelium was associated with amelioration of symp- 152 toms (burning, pain, and photophobia) in all patients whose grafts were considered successful (see Table 1 in the Supplementary Appendix). Normal vision was restored in only those patients with undamaged corneal stroma, however (Fig. 3 , and . We observed regeneration of the corneal epithelium that was sufficient to resurface the donor stroma in all the patients treated with keratoplasty. Permanent recovery of at least 0.6 visual acuity (range, 0.6 to 1.0) was attained in 21 patients (Table 1 in the Supplementary Appendix). The remaining 25 patients had partial recovery of vision (up to 0.5 visual acuity). Figure  3B shows the results of limbal stem-cell grafting followed by penetrating keratoplasty in the eyes of three patients who had total limbal stem-cell deficiency, complete corneal opacification, stromal scarring, and reduced visual acuity (<0.1, counting fingers and perceiving hand movements) before treatment. After keratoplasty, which was performed between 4 and 6.5 years after grafting, the cornea was transparent in each of the patients and their visual acuity ranged from 0.3 to 0.9. Figure 3 in the Supplementary Appendix shows the eyes of Patient 24 who had severe bilateral limbal stem-cell deficiency that resulted from an alkali burn in 1948. He was treated with grafts of limbal stem-cell cultures prepared from a single biopsy specimen (taken from the left eye), followed by penetrating keratoplasty. Both corneal surfaces were restored. Follow-up at 2 years (right eye) and 5 years (left eye) showed that both eyes were stable. At follow-up his best-corrected visual acuity was 0.6 and 0.7 in the left and right eyes, respectively. The percentage of p63-bright cells was calculated on subconfluent primary cultures used to seed graftable secondary cultures. These analyses were performed on only 82 cultures, since the relation between p63 cells and limbal stem cells was not discovered until 2001.
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The box plots in Panel A, which are based on a Kruskal-Wallis analysis, show the relationship between the percentage of p63-bright cells and the three outcomes of success, partial success, and failure. The horizontal line within each box represents the median value; the bottom and top lines of the box represent the 25th and 75th percentiles, respectively; and the horizontal lines below and above the box represent the lowest and highest values, respectively, with outliers excluded. In Panel B, also based on a Kruskal-Wallis test, grafts scored as successes, partial successes, and failures were evaluated in relation to the percentage of p63-bright holoclone-forming cells (>3% vs. ≤3%). The cultures that contained more than 3% p63-bright cells were successful in 78.1% of eyes and failed in 8.2% of eyes, whereas cultures that contained smaller percentages of such cells were successful in 11.1% of eyes and failed in 66.7% of eyes. Thus, the percentage of p63-bright cells can be used to predict the clinical outcome of limbal stem-cell cultures. Preservation of holoclones requires culture with selected 3T3 feeder cells and fetal-calf serum, 6, 22, 23 and this culture method has been used worldwide since the 1980s 6,7 to treat patients with massive full-thickness burns. 18, 19, 24 During the past 30 years, no adverse effects have been reported, and this method has been approved for use in the United States, Japan, Italy, and South Korea. 6, 7 Retention of holoclones also requires appropriate substrates for the cultivation of cells; both fibrin and plastic have been shown to preserve holoclone-forming cells. [18] [19] [20] Alternative methods involving other reagents have been proposed that obviate the use of feeder cells, serum, or both, 6,17 since some investigators consider these reagents to be potentially harmful. 25 The retention of stem cells when these alternative methods are used has not been investigated.
Allogeneic and buccal keratinocytes have been used as sources of grafts in previous clinical experimental studies to treat limbal stem-cell deficiency. 6,17 Allogeneic keratinocytes -even when frozen or lyophilized -improve healing of partial-thickness or small skin wounds by stimulating resident cells. 26, 27 However, engraftment of these allogeneic cells is not permanent, 26 and it seems unlikely that the presence of stem cells is required for their clinical effect. Donor epithelial cells have not been recovered from the ocular sur- Table 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org), who had total limbal stem-cell deficiency due to an acid burn (image at left). His visual acuity was reduced to counting fingers. A graft of autologous limbal cultures was sufficient to regenerate functional corneal epithelium (image at right) and to restore normal vision (visual acuity, 0.7), since the eye had no stromal scarring. Panel B shows the eyes of Patients 22, 26, and 46 (see Table 1 in the Supplementary Appendix), which were damaged by alkali burns and were treated with unsuccessful surgery 13, 30, and 3 years before admission, respectively. All three eyes had total limbal stem-cell deficiency, complete corneal opacification, and stromal scarring (images at left). Vision was reduced to counting fingers (in Patient 22) or perceiving hand movements (in Patients 26 and 46). In all three patients, autologous limbal stem-cell cultures successfully regenerated functional corneal epithelium. To improve their visual acuity after grafting, the patients underwent penetrating keratoplasty. In all three eyes, the engrafted limbal stem cells resurfaced the donor stroma. At the last follow-up visits (at 6, 6.5, and 4 years, respectively), all eyes were covered by stable corneal epithelium (images at right). The keratoplasty resulted in complete restoration of visual acuity in Patients 22 and 46 (0.9 and 0.8, respectively). The visual acuity of Patient 26 increased to only 0.3 because of a concomitant amblyopia (the alkali burn had occurred 30 years before admission). In Patient 46, the follow-up image shows that the conjunctival vessels stop at the conjunctival-corneal boundary (arrowheads); they do not invade the restored corneal surface.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF GEORGIA on July 28, 2011. For personal use only. No other uses without permission.
Copyright © 2010 Massachusetts Medical Society. All rights reserved.
face in studies that looked at long-term outcomes, 28,29 and it seems unlikely that these cells would regenerate functional epithelium in patients with total limbal stem-cell deficiency, nor is there evidence that buccal keratinocytes can generate bona fide corneal epithelium. 30 If limbal stem-cell deficiency is only partial, allogeneic or oral keratinocytes may be sufficient to stimulate resident limbal cells to regenerate corneal epithelium. Additional studies to test this hypothesis are warranted. The same argument might hold true for the effect of autologous cultures on corneal regeneration. Nevertheless, the association that we observed -between the percentage of p63-bright cells and clinical success -was never related to a nonspecific stimulatory effect of the transplanted culture on resident stem cells.
In conclusion, our study shows that in patients with limbal stem-cell deficiency who received cultured limbal stem-cell grafts for corneal transplantation, the clinical results were successful at up to 10 years (at a median of 2 years) in more than 75% of the patients treated. Cultures of limbal stem cells thus represent a source of cells for transplantation in the treatment of burn-induced destruction of the human cornea.
